24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2022
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2022 VC Survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Ichilov Medical Center
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
21:40
Florida enthusiastically welcomes Calcalist conference to Miami
18:24
Bitsight acquires Cybersixgill in $115 million deal to strengthen cyber risk management
16:04
Full list of Israeli startup M&As in 2024
16:00
Immunai and Teva launch multi-tear AI collaboration for smarter drug development
More stories
Buzz
Most popular
Daily
Weekly
1
Is your solitaire opponent actually a bot?
2
CyberArk and Wiz join forces to enhance cloud security in multi-cloud environments
3
Silverfort acquires Rezonate for several tens of millions to expand cloud security reach
4
Oracle CEO: "If we continue on our current trajectory, reaching a valuation of a trillion dollars is inevitable"
5
Nokia acquires former unicorn Rapid to boost API-driven 5G monetization
More news
Ichilov Medical Center
2 stories about Ichilov Medical Center
"The genome project will change the face of medicine in Israel and save human lives"
10.11.24
|
Roni Dori
Psifas is an ambitious new genome project aiming to create a genetic database of Israel’s citizens, with a budget of NIS 250 million. The collected information already provides information that will make it possible to treat life-threatening diseases in the subjects. The hope is that after accumulating 100,000 samples, the database will help jumpstart the biotech industry. CEO Prof. Gabi Barbash: "Psifas is a great achievement and advantage for Israel, which aspires to become a global hub of biotechnological information."
BioLight to partner with Ichilov Medical Center to develop innovative ophthalmology technologies
29.11.21
|
CTech
According to the terms of the agreement, the company will retain the primary right to license technologies developed at Ichilov
Please ensure Javascript is enabled for purposes of
website accessibility